Thermo Fisher Completes Lomb Acquisition | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it has completed the acquisition of Lomb Scientific, a provider of lab chemicals, consumables, and instruments in Australia and New Zealand, for an undisclosed sum.

Lomb Scientific, which will be integrated into Thermo Fisher's Laboratory Products and Services and Analytical Technologies segments, had revenues in 2009 of A$34 million ($32.8 million), and it has around 100 employees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.